Expleo Solutions Ltd

Expleo Solutions Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Expleo Solutions Ltd

₹ 1,431 -3.96%
26 May - close price
sqs-bfsi.com BSE: 533121 NSE : EXPLEOSOL
About

Expleo Solutions Ltd is an India-based software service provider primarily delivering software validation and verification services to the BFSI industry worldwide.[1]

Key Points

Service Offerings
The company offers various testing services for BFSI viz. test management, functional testing, non-function testing, product testing, compliance testing, UX/CX testing, mobile testing and managed testing services. It also offers big data technologies viz. big data development, big data testing and big data administration. [1]

Website BSE NSE
  • Market Cap ₹ 1,467 Cr.
  • Current Price ₹ 1,431
  • High / Low ₹ 1,539 / 1,111
  • Stock P/E 11.0
  • Book Value ₹ 517
  • Dividend Yield 0.35 %
  • ROCE 45.7 %
  • ROE 34.1 %
  • Face Value ₹ 10.0
Edit ratios

Pros

  • Company is almost debt free.
  • Company is expected to give good quarter
  • Company has delivered good profit growth of 33.2% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 29.8%

Cons

  • Working capital days have increased from 66.3 days to 94.3 days

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Sector: IT - Software Industry: Computers - Software - Medium / Small

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
76 76 74 72 79 88 97 106 196 127 131 240 231
60 56 56 58 63 73 81 89 166 102 104 168 188
Operating Profit 16 19 18 14 17 15 16 17 30 26 27 72 43
OPM % 21% 26% 24% 19% 21% 17% 17% 16% 15% 20% 21% 30% 19%
3 2 1 5 1 4 1 0 6 1 2 13 4
Interest 0 0 0 0 0 0 0 0 1 0 0 1 0
Depreciation 1 1 1 2 1 2 2 2 5 4 4 7 7
Profit before tax 17 19 17 17 15 17 15 15 30 23 25 77 39
Tax % 20% 26% 26% 24% 29% 25% 27% 26% 28% 24% 29% 28% 26%
Net Profit 14 14 13 13 11 13 11 11 22 17 18 55 29
EPS in Rs 13.63 13.91 12.28 12.30 10.72 12.49 10.80 11.10 21.20 16.75 17.17 54.00 28.34
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
121 161 194 214 264 260 271 283 270 301 405 903
109 131 155 177 210 219 231 230 217 231 327 703
Operating Profit 13 30 40 37 54 41 40 53 53 70 77 200
OPM % 11% 19% 20% 17% 20% 16% 15% 19% 20% 23% 19% 22%
10 2 10 2 6 1 13 6 8 5 4 16
Interest 0 1 2 2 0 0 0 0 1 1 1 2
Depreciation 4 5 6 5 4 5 6 6 6 6 8 28
Profit before tax 18 26 42 32 56 37 48 54 54 68 72 186
Tax % 38% 27% 29% 32% 34% 36% 33% 32% 26% 26% 25% 28%
Net Profit 11 19 30 22 37 24 32 36 40 50 54 134
EPS in Rs 11.32 19.20 29.26 20.53 34.68 22.29 29.86 33.79 38.92 49.20 52.57 130.59
Dividend Payout % 44% 31% 31% 117% 69% 108% 80% -0% -0% -0% -0% 6%
Compounded Sales Growth
10 Years: 19%
5 Years: 27%
3 Years: 50%
TTM: 123%
Compounded Profit Growth
10 Years: 21%
5 Years: 33%
3 Years: 50%
TTM: 149%
Stock Price CAGR
10 Years: 35%
5 Years: 21%
3 Years: 102%
1 Year: 15%
Return on Equity
10 Years: 28%
5 Years: 29%
3 Years: 30%
Last Year: 34%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
10 10 10 11 11 11 11 11 10 10 10 16
Reserves 65 78 98 91 98 116 118 128 142 192 245 515
-0 14 12 10 -0 -0 -0 -0 -0 7 13 26
26 26 27 54 73 43 63 53 62 56 76 174
Total Liabilities 102 128 147 165 182 171 191 192 214 264 344 730
11 31 27 24 25 27 22 19 26 25 39 142
CWIP 0 0 1 1 -0 -0 -0 -0 -0 -0 -0 6
Investments -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0 -0
91 97 119 139 157 144 169 173 188 239 305 582
Total Assets 102 128 147 165 182 171 191 192 214 264 344 730

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
6 18 24 33 58 42 25 41 17 66 38 23
-0 -23 -1 -6 11 -14 -18 24 -7 -44 16 -36
-4 6 -13 -11 -39 -31 -31 -26 -29 -3 -3 -7
Net Cash Flow 2 2 10 16 30 -2 -23 38 -19 19 51 -19

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023
Debtor Days 71 93 105 97 75 60 92 59 103 74 88 97
Inventory Days
Days Payable
Cash Conversion Cycle 71 93 105 97 75 60 92 59 103 74 88 97
Working Capital Days 71 62 68 23 -7 8 21 15 50 50 55 94
ROCE % 26% 31% 40% 29% 51% 31% 38% 40% 38% 39% 31% 46%

Shareholding Pattern

Numbers in percentages

Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021 Sep 2021 Dec 2021 Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023
56.17 56.17 56.17 56.17 56.17 56.17 56.17 56.17 56.17 56.17 56.17 56.17
0.00 0.00 0.00 0.27 0.42 0.17 0.09 0.13 0.00 0.08 0.01 0.01
0.00 0.55 0.99 1.24 1.24 1.83 2.16 2.08 2.39 3.35 4.52 4.74
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.01
43.83 43.28 42.85 42.32 42.17 41.83 41.58 41.62 41.44 40.39 39.30 39.07

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls